BDBM481741 US10913733, Example 52::US10913733, Example 54
SMILES: C[C@H]1CC(CCN1Cc1cnc(NC(C)=O)s1)=Cc1ccc(F)nc1
InChI Key: InChIKey=PQNPJEFINNNRGY-LBPRGKRZSA-N
Data: 2 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM481741 (US10913733, Example 52 | US10913733, Example 54) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 0.389 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. US Patent | Assay Description Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p... | US Patent US10913733 (2021) | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
N-acetyl-beta-D-glucosaminidase (O-GlcNAcase) (Homo sapiens (Human)) | BDBM481741 (US10913733, Example 52 | US10913733, Example 54) | PDB KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | 11.8 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Alectos Therapeutics Inc.; Merck Sharp & Dohme Corp. US Patent | Assay Description Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p... | US Patent US10913733 (2021) | |||||||||||
More data for this Ligand-Target Pair |